1. 1. AIDS Prevention Information Network, Japan Foundation for AIDS Prevention. Number of HIV testing in local health centers, annual report for trends in AIDS. https://api-net.jfap.or.jp/status/japan/data/2019/nenpo/kensa.pdf (accessed June 26, 2021). (in Japanese)
2. 2. Ejima K, Koizumi Y, Yamamoto N, Rosenberg M, Ludema C, Bento AI, Yoneoka D, Ichikawa S, Mizushima D, Iwami S. HIV testing by public health centers and municipalities and new HIV cases during the COVID-19 pandemic in Japan. J Acquir Immune Defic Syndr. 2021; 87:e182-e187.
3. 3. World Health Organization. Consolidated guidelines on HIV testing services 2019. https://www.who.int/publications/i/item/978-92-4-155058-1 (accessed June 25, 2021).
4. 4. Bertagnolio S, Parkin NT, Jordan M, Brooks J, Garcia-Lerma JG. Dried blood spots for HIV-1 drug resistance and viral load testing. A review of current knowledge and WHO efforts for global HIV drug resistance surveillance. AIDS Rev. 2010; 12:195-208.
5. 5. Chang J, de Sousa A, Sabatier J, Assane M, Zhang G, Bila D, Vaz P, Alfredo C, Cossa L, Bhatt N, Koumans EH, Yang C, Rivadeneira E, Jani I, Houston JC. Performance characteristics of finger-stick dried blood spots (DBS) on the determination of human immunodeficiency virus (HIV) treatment failure in a pediatric population in Mozambique. PLoS One. 2017; 12:e0181054.